Metabolic Syndrome and Complication Risk in Type 1 Diabetes
May 1, 2021
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Macrina Ghali, PharmD Candidate 2021, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences
Researchers sought to identify the prevalence of metabolic syndrome in patients with type 1 diabetes and its relationship to diabetic complication development.
Metabolic syndrome is strongly associated with type 2 diabetes and insulin resistance. It encompasses certain cardiovascular risk factors, including abdominal obesity, dyslipidemia, hypertension, insulin resistance, and prothrombic and proinflammatory states. As obesity rates have risen, an association between metabolic syndrome and type 1 diabetes has developed. Prompt identification of these patients allows for rapid management and reduction of diabetic complications. Furthermore, previous studies have shown that metabolic syndrome in younger patients with type 2 diabetes reduces the complications as aging continues. The use of metformin in patients with type 1 diabetes has also been shown to reduce atherosclerotic events. Researchers in Australia examined metabolic syndrome prevalence in patients with type 1 diabetes and the relationship to microvascular and macrovascular complications across age groups. They also assessed the use of metformin in patients with type 1 diabetes....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.